Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].

Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology - 1 Apr 2010

Higuchi Hisashi

Abstract excerpt

In a milnacipran study, ninety-six patients with major depressive disorder were treated with milnacipran, 50-100 mg/day, for 6 weeks. Severity of depression was assessed with the Montgomery and Asberg Depression Rating Scale. The purpose of this study was to determine whether norepinephrine transporter (NET) gene and serotonin transporter (5-HTT) gene polymorphisms are associated with the antidepressant response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Cyclopropanes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Fluvoxamine

Share to Forecasting

Share to Norepinephrine Plasma Membrane Transport Proteins

Share to Racial Groups

Share to Selective Serotonin Reuptake Inhibitors

Source

Identifiers

PMID: 20491280

Genes

HTT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].PMID 20491280Read ↗

Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms.Semantic proximity Read ↗

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.Semantic proximity Read ↗

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.Semantic proximity Read ↗

[Genetic and clinical predictors of treatment efficacy in depressive disorders].Semantic proximity Read ↗

Influence of the tyrosine hydroxylase val81met polymorphism and catechol-O-methyltransferase val158met polymorphism on the antidepressant effect of milnacipran.Semantic proximity Read ↗

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.Semantic proximity Read ↗

Evidence for association between genetic variants of p75 neurotrophin receptor (p75NTR) gene and antidepressant treatment response in Chinese major depressive disorder.Semantic proximity Read ↗

Bcl1 polymorphism of the glucocorticoid receptor gene and treatment response to milnacipran and fluvoxamine in Japanese patients with depression.Semantic proximity Read ↗

Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.Semantic proximity Read ↗

[Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response].Semantic proximity Read ↗

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.Semantic proximity Read ↗

Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.